AJP - Lung Information on EB 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol 292: L529-L536, 2007. First published October 20, 2006; doi:10.1152/ajplung.00082.2006
1040-0605/07 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
292/2/L529    most recent
00082.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (10)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gazdhar, A.
Right arrow Articles by Geiser, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gazdhar, A.
Right arrow Articles by Geiser, T.

Gene transfer of hepatocyte growth factor by electroporation reduces bleomycin-induced lung fibrosis

Amiq Gazdhar,1,2,* Patrick Fachinger,1,* Coretta van Leer,2 Jaroslaw Pierog,1 Mathias Gugger,3 Robert Friis,4 Ralph A. Schmid,1 and Thomas Geiser2,4

Divisions of 1Thoracic Surgery and 2Pulmonary Medicine, University Hospital, and 3Institute of Pathology and 4Department of Clinical Research, University of Bern, Bern, Switzerland

Submitted 8 March 2006 ; accepted in final form 17 October 2006

Abnormal alveolar wound repair contributes to the development of pulmonary fibrosis after lung injury. Hepatocyte growth factor (HGF) is a potent mitogenic factor for alveolar epithelial cells and may therefore improve alveolar epithelial repair in vitro and in vivo. We hypothesized that HGF could increase alveolar epithelial repair in vitro and improve pulmonary fibrosis in vivo. Alveolar wound repair in vitro was determined using an epithelial wound repair model with HGF-transfected A549 alveolar epithelial cells. Electroporation-mediated, nonviral gene transfer of HGF in vivo was performed 7 days after bleomycin-induced lung injury in the rat. Alveolar epithelial repair in vitro was increased after transfection of wounded epithelial monolayers with a plasmid encoding human HGF, pCikhHGF [human HGF (hHGF) gene expressed from the cytomegalovirus (CMV) immediate-early promoter and enhancer] compared with medium control. Electroporation-mediated in vivo HGF gene transfer using pCikhHGF 7 days after intratracheal bleomycin reduced pulmonary fibrosis as assessed by histology and hydroxyproline determination 14 days after bleomycin compared with controls treated with the same vector not containing the HGF sequence (pCik). Lung epithelial cell proliferation was increased and apoptosis reduced in hHGF-treated lungs compared with controls, suggesting increased alveolar epithelial repair in vivo. In addition, profibrotic transforming growth factor-beta1 (TGF-beta1) was decreased in hHGF-treated lungs, indicating an involvement of TGF-beta1 in hHGF-induced reduction of lung fibrosis. In conclusion, electroporation-mediated gene transfer of hHGF decreases bleomycin-induced pulmonary fibrosis, possibly by increasing alveolar epithelial cell proliferation and reducing apoptosis, resulting in improved alveolar wound repair.

repair; pulmonary fibrosis; gene therapy; transforming growth factor-beta1



Address for reprint requests and other correspondence: R. A. Schmid, Division of Thoracic Surgery, Univ. Hospital, CH-3010 Bern, Switzerland (e-mail: ralph.schmid{at}insel.ch)




This article has been cited by other articles:


Home page
ERRHome page
B. D. Uhal
The role of apoptosis in pulmonary fibrosis
Eur. Respir. Rev., December 1, 2008; 17(109): 138 - 144.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. D. Huebner, D. S. Jassal, O. Halevy, M. Pines, and J. E. Anderson
Functional resolution of fibrosis in mdx mouse dystrophic heart and skeletal muscle by halofuginone
Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1550 - H1561.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.